475 related articles for article (PubMed ID: 24225201)
61. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
62. Heart failure: ivabradine is no better than optimised beta-blocker therapy.
Prescrire Int; 2011; 20(118):189-90. PubMed ID: 21751757
[TBL] [Abstract][Full Text] [Related]
63. Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
Böhm M; Abdin A; Slawik J; Mahfoud F; Borer J; Ford I; Swedberg K; Tavazzi L; Batailler C; Komajda M
Eur J Heart Fail; 2023 Aug; 25(8):1429-1435. PubMed ID: 37092340
[TBL] [Abstract][Full Text] [Related]
64. Heart rate reduction with ivabradine in patients with acute decompensated systolic heart failure.
Sargento L; Satendra M; Longo S; Lousada N; dos Reis RP
Am J Cardiovasc Drugs; 2014 Jun; 14(3):229-35. PubMed ID: 24452599
[TBL] [Abstract][Full Text] [Related]
65. [Effect of the I(f) channel blocker ivabradine on the parameters of external respiration function in patients with chronic obstructive pulmonary disease in its stable course period].
Komlev AD; Kuziaev AI; Laskin GM; Kuzenkova VE; Kolosova MV
Ter Arkh; 2010; 82(3):23-5. PubMed ID: 20564916
[TBL] [Abstract][Full Text] [Related]
66. The prognostic role of chronic obstructive pulmonary disease in ST-elevation myocardial infarction after primary angioplasty.
Lazzeri C; Valente S; Attanà P; Chiostri M; Picariello C; Gensini GF
Eur J Prev Cardiol; 2013 Jun; 20(3):392-8. PubMed ID: 22023803
[TBL] [Abstract][Full Text] [Related]
67. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
68. Risk following hospitalization in stable chronic systolic heart failure.
Abrahamsson P; Swedberg K; Borer JS; Böhm M; Kober L; Komajda M; Lloyd SM; Metra M; Tavazzi L; Ford I
Eur J Heart Fail; 2013 Aug; 15(8):885-91. PubMed ID: 23460732
[TBL] [Abstract][Full Text] [Related]
69. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study.
Böhm M; Borer J; Ford I; Gonzalez-Juanatey JR; Komajda M; Lopez-Sendon J; Reil JC; Swedberg K; Tavazzi L
Clin Res Cardiol; 2013 Jan; 102(1):11-22. PubMed ID: 22575988
[TBL] [Abstract][Full Text] [Related]
70. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
71. COPD predicts mortality in HF: the Norwegian Heart Failure Registry.
De Blois J; Simard S; Atar D; Agewall S;
J Card Fail; 2010 Mar; 16(3):225-9. PubMed ID: 20206897
[TBL] [Abstract][Full Text] [Related]
72. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
[TBL] [Abstract][Full Text] [Related]
73. The effect of ivabradine on functional capacity in patients with chronic obstructive pulmonary disease.
Mahmoud K; Kassem HH; Baligh E; ElGameel U; Akl Y; Kandil H
Clin Med (Lond); 2016 Oct; 16(5):419-422. PubMed ID: 27697801
[TBL] [Abstract][Full Text] [Related]
74. Heart rate and heart failure: the role of ivabradine therapy.
Reil JC; Böhm M
Curr Opin Cardiol; 2013 May; 28(3):326-31. PubMed ID: 23549235
[TBL] [Abstract][Full Text] [Related]
75. Inadequate heart rate control is associated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study.
Andrikopoulos G; Pastromas S; Kartalis A; Toli K; Mantas I; Tzeis S; Kyrpizidis C; Olympios C; Manolis AJ; Foussas S; Kranidis A; Pras A; Pipilis A; Chryssos D; Gotsis A; Trikas A; Richter D; Alexopoulos D; Parthenakis F; Theodorakis G; Konstantinides S; Vardas P
Hellenic J Cardiol; 2012 Mar; 53(2):118-26. PubMed ID: 22484777
[TBL] [Abstract][Full Text] [Related]
76. Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine.
Raja DC; Kapoor A; Sinha A; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel P
Indian Heart J; 2018; 70(2):246-251. PubMed ID: 29716702
[TBL] [Abstract][Full Text] [Related]
77. Effectiveness and safety of ivabradine in Chinese patients with chronic heart failure: an observational study.
Zhou J; Xu Y; Zheng Z; Zhang S; Yang J; Zhang Y; Tang B; Han H; Zhang Q; Liu F; Ding W; Qian C; Su G; Liu X; Shen Y; Shi B; Kong X; Ge Z; Zhang P; Guo X; Zhang H; Sun Y; Dong Y; Fu G; Feng L; Ge J;
ESC Heart Fail; 2024 Apr; 11(2):846-858. PubMed ID: 38193606
[TBL] [Abstract][Full Text] [Related]
78. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
[TBL] [Abstract][Full Text] [Related]
79. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
[TBL] [Abstract][Full Text] [Related]
80. Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme.
Hawkins NM; Wang D; Petrie MC; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Solomon SD; Ostergren J; Michelson EL; Pocock SJ; Maggioni AP; McMurray JJ;
Eur J Heart Fail; 2010 Jun; 12(6):557-65. PubMed ID: 20356870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
